Estimate Recalculated Nov 1, 2024 02:24PM EST
Augustine Lawlor does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PHARMATHENE, INC, CRITICAL THERAPEUTICS INC, ADVANCIS PHARMACEUTICAL CORP, ACTIVBIOTICS INC, TETRALOGIC PHARMACEUTICALS Corp, Radius Health, Inc., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., THRESHOLD PHARMACEUTICALS INC, GLOBEIMMUNE INC, MEMORY PHARMACEUTICALS CORP, LEAP THERAPEUTICS, INC., Cardiovascular Systems Inc, CATALYST BIOSCIENCES, INC., and HUMAN GENOME SCIENCES INC.
Augustine Lawlor's CIK is 0001262327
2021 was Augustine Lawlor's most active year for acquiring shares with 11 total transactions. Augustine Lawlor's most active month to acquire stocks was the month of July. 2012 was Augustine Lawlor's most active year for disposing of shares, totalling 9 transactions. Augustine Lawlor's most active month to dispose stocks was the month of June. 2012 saw Augustine Lawlor paying a total of $66,740.72 for 42,152 shares, this is the most they've acquired in one year. In 2012 Augustine Lawlor cashed out on 190,595 shares for a total of $2,715,978.75, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!